Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension

Actelion Pharmaceuticals is now promoting Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension. ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login